These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 38970797)
1. Mesonephric-type adenocarcinomas of the ovary: prevalence, diagnostic reproducibility, outcome, and value of PAX2. Köbel M; Kang EY; Lee S; Ogilvie T; Terzic T; Wang L; Wiebe NJ; Al-Shamma Z; Cook LS; Nelson GS; Stewart CJ; von Deimling A; Kommoss FK; Lee CH J Pathol Clin Res; 2024 Jul; 10(4):e12389. PubMed ID: 38970797 [TBL] [Abstract][Full Text] [Related]
2. A Comparison of GATA3, TTF1, CD10, and Calretinin in Identifying Mesonephric and Mesonephric-like Carcinomas of the Gynecologic Tract. Pors J; Cheng A; Leo JM; Kinloch MA; Gilks B; Hoang L Am J Surg Pathol; 2018 Dec; 42(12):1596-1606. PubMed ID: 30148742 [TBL] [Abstract][Full Text] [Related]
3. Accurate Distinction of Ovarian Clear Cell From Endometrioid Carcinoma Requires Integration of Phenotype, Immunohistochemical Predictions, and Genotype: Implications for Lynch Syndrome Screening. Rodriguez M; Kang EY; Farrington K; Cook LS; Le ND; Karnezis AN; Lee CH; Nelson GS; Terzic T; Lee S; Köbel M Am J Surg Pathol; 2021 Nov; 45(11):1452-1463. PubMed ID: 34534137 [TBL] [Abstract][Full Text] [Related]
4. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma. Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933 [TBL] [Abstract][Full Text] [Related]
5. Premature Classification of Early-stage Endometrioid Ovarian Carcinoma With Mesonephric-like Differentiation as Mesonephric-like Adenocarcinoma. Miyama Y; Ogasawara A; Hasegawa K; Yasuda M Int J Gynecol Pathol; 2024 Jul; 43(4):362-372. PubMed ID: 38870078 [TBL] [Abstract][Full Text] [Related]
6. Ovarian mesonephric-like adenocarcinoma arising in serous borderline tumor: a case report with complex morphological and molecular analysis. Dundr P; Gregová M; Němejcová K; Bártů M; Hájková N; Hojný J; Stružinská I; Fischerová D Diagn Pathol; 2020 Jul; 15(1):91. PubMed ID: 32693840 [TBL] [Abstract][Full Text] [Related]
7. High-grade Endometrioid Carcinoma of the Ovary: A Clinicopathologic Study of 30 Cases. Assem H; Rambau PF; Lee S; Ogilvie T; Sienko A; Kelemen LE; Köbel M Am J Surg Pathol; 2018 Apr; 42(4):534-544. PubMed ID: 29309296 [TBL] [Abstract][Full Text] [Related]
8. Ovarian Combined Low-grade Serous and Mesonephric-like Adenocarcinoma: Further Evidence for A Mullerian Origin of Mesonephric-like Adenocarcinoma. McCluggage WG; Vosmikova H; Laco J Int J Gynecol Pathol; 2020 Jan; 39(1):84-92. PubMed ID: 30575604 [TBL] [Abstract][Full Text] [Related]
9. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma. McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic Value of Immunostaining for Thyroid Transcription Factor 1 (TTF1) and Paired Box 8 (PAX8) in Distinguishing Pulmonary Metastases of Mesonephric and Mesonephric-like Adenocarcinomas from Primary Lung Adenocarcinomas. Ji N; Lee Y; Lee SH; Kim HS Anticancer Res; 2024 May; 44(5):2159-2170. PubMed ID: 38677751 [TBL] [Abstract][Full Text] [Related]
11. Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary. Rambau PF; McIntyre JB; Taylor J; Lee S; Ogilvie T; Sienko A; Morris D; Duggan MA; McCluggage WG; Köbel M Am J Surg Pathol; 2017 May; 41(5):685-695. PubMed ID: 28125452 [TBL] [Abstract][Full Text] [Related]
12. Morphological and Immunohistochemical Reevaluation of Tumors Initially Diagnosed as Ovarian Endometrioid Carcinoma With Emphasis on High-grade Tumors. Lim D; Murali R; Murray MP; Veras E; Park KJ; Soslow RA Am J Surg Pathol; 2016 Mar; 40(3):302-12. PubMed ID: 26551621 [TBL] [Abstract][Full Text] [Related]
13. Mixed Mesonephric-like Adenocarcinoma, Clear Cell Carcinoma, and Endometrioid Carcinoma Arising from an Endometriotic Cyst. Nagase S; Saeki H; Ura A; Terao Y; Matsumoto T; Yao T Int J Surg Pathol; 2024 Sep; 32(6):1140-1148. PubMed ID: 37994045 [TBL] [Abstract][Full Text] [Related]
14. Hormone receptor-negative, thyroid transcription factor 1-positive uterine and ovarian adenocarcinomas: report of a series of mesonephric-like adenocarcinomas. McFarland M; Quick CM; McCluggage WG Histopathology; 2016 Jun; 68(7):1013-20. PubMed ID: 26484981 [TBL] [Abstract][Full Text] [Related]
15. Adenocarcinomas of the Gynecologic Tract Involving the Urinary Bladder: A Series of 16 Cases Potentially Mimicking Urothelial Malignancy. Russell DH; Epstein JI; Kryvenko ON; Schlumbrecht M; Jorda M; Pinto A Arch Pathol Lab Med; 2024 Jun; 148(6):705-714. PubMed ID: 37948107 [TBL] [Abstract][Full Text] [Related]
16. Mesonephric-like Differentiation of Ovarian Endometrioid and High-grade Serous Carcinomas: Clinicopathological and Molecular Characteristics Distinct from Those of Mesonephric-like Adenocarcinoma. Choi KH; Kim H; Bae GE; Lee SH; Woo HY; Kim HS Anticancer Res; 2021 Sep; 41(9):4587-4601. PubMed ID: 34475087 [TBL] [Abstract][Full Text] [Related]
17. Ovarian Endometrioid Carcinoma Misdiagnosed as Mucinous Carcinoma: An Underrecognized Problem. Woodbeck R; Kelemen LE; Köbel M Int J Gynecol Pathol; 2019 Nov; 38(6):568-575. PubMed ID: 30480647 [TBL] [Abstract][Full Text] [Related]
18. [Adenocarcinomas with mesonephric features in gynecologic tract: a clinicopathological analysis of seven cases]. Liang Y; Ruan HJ; Wang WS; Yu MH; Chen XD; Zhang XF Zhonghua Bing Li Xue Za Zhi; 2021 Jul; 50(7):791-795. PubMed ID: 34405616 [No Abstract] [Full Text] [Related]
19. Corded and hyalinized mesonephric-like adenocarcinoma of the uterine corpus: report of a case mimicking endometrioid carcinoma. Patel V; Kipp B; Schoolmeester JK Hum Pathol; 2019 Apr; 86():243-248. PubMed ID: 30172914 [TBL] [Abstract][Full Text] [Related]
20. Comprehensive Immunohistochemical Analysis of Mesonephric Marker Expression in Low-grade Endometrial Endometrioid Carcinoma. Lee Y; Choi S; Kim HS Int J Gynecol Pathol; 2024 May; 43(3):221-232. PubMed ID: 37566876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]